Alembic Limited (ALEMBICLTD) Fair Value & Analysis
Real Estate · IN · Market cap ₹23.5B
Fair value as of: Jun 29, 2026
Analysis
Alembic Limited (ALEMBICLTD) currently trades at ₹91.54, while our model-based Fair Value estimate is ₹60.75 — implying the stock looks roughly 33.6% overvalued today. We read business quality at 97/100 (high quality), in the Real Estate sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).
About the company
Alembic Limited engages in real estate business in India and internationally. It operates through Active Pharmaceutical Ingredient (API) and Real Estate segments. The company constructs residential and commercial real estate projects; provides project management and marketing consultancy services; and leases commercial properties. It also manufactures and markets fermentation and chemistry based active pharmaceutical ingredient; and engages in research and development activities. In addition, it is involved in power generation through co-generation plants and wind power sources. The company serves individuals, entrepreneurs, corporates, business houses, HNIs, NRIs, and pharmaceutical companies. The company was incorporated in 1907 and is based in Vadodara, India. Alembic Limited is a subsidiary of Nirayu Pvt. Ltd.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is Alembic Limited (ALEMBICLTD) undervalued?
What is the fair value of ALEMBICLTD?
What is the quality score of ALEMBICLTD?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.